Track topics on Twitter Track topics that are important to you
KOL Perspectives: Adaptive Trial Designs in IBD
This KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.
Current challenges in IBD clinical trials
Adaptive Phase II/III trial designs
Guselkumab's Phase II/III trial in Crohn's disease
Novel clinical trials in IBD
Most KOLs highlighted that recruitment is the greatest challenge in IBD clinical trials, both across Crohn's disease UC
Most KOLs flagged Phase II/III trials could accelerate development, but may limit ability to analyze data adapt trial design
Most KOLs cited 812 weeks as being the minimum duration of a Phase II trial in IBD, with openlabel extensions favored by all KOLs.
The insight briefing is based on Sociable Pharma's analysis of primary research with our IBD key opinion leaders KOLs.
In total, we conducted interviews with 10 KOLs
5 Europebased 5 N. Americabased
Interviews performed during July 2018
KOL data is analyzed to produce
Charts summarizing KOL opinions
Chart callouts of key information details
Summary of KOL reporting trends
Insight from Sociable Pharma's analysts
Reasons to buy
Combines Qualitative semiquantitative insight from key opinion leaders on Adaptive trial designs in IBD
Includes insight recommendations from our diseasespecific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data emerging trends on management of IBD
Provides costeffective support for your advisory boards, with topics acting as a catalyst for further expert discussion.NEXT ARTICLE
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...